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Abstract
Background: Deamination of cytosine to produce uracil is a common and potentially mutagenic
lesion in genomic DNA. U•G mismatches occur spontaneously throughout the genome, where
they are repaired by factors associated with the base excision repair pathway. U•G mismatches are
also the initiating lesion in immunoglobulin gene diversification, where they undergo mutagenic
processing by redundant pathways, one dependent upon uracil excision and the other upon
mismatch recognition by MutSα. While UNG is well known to initiate repair of uracil in DNA, the
ability of MutSα to direct correction of this base has not been directly demonstrated.
Results: Using a biochemical assay for mismatch repair, we show that MutSα can promote efficient
and faithful repair of U•G mismatches, but does not repair U•A pairs in DNA. This contrasts with
UNG, which readily excises U opposite either A or G. Repair of U•G by MutSα depends upon
DNA polymerase δ (pol δ), ATP, and proliferating cell nuclear antigen (PCNA), all properties of
canonical mismatch repair.
Conclusion: These results show that faithful repair of U•G can be carried out by either the
mismatch repair or base excision repair pathways. Thus, the redundant functions of these pathways
in immunoglobulin gene diversification reflect their redundant functions in faithful repair. Faithful
repair by either pathway is comparably efficient, suggesting that mismatch repair and base excision
repair share the task of faithful repair of genomic uracil.
Background
Uracil in DNA is potentially mutagenic and a single unre-
paired uracil opposite guanine can cause a C→T transition
mutation upon replication, constituting a significant
potential source of DNA damage. Genomic uracil can be
introduced by deamination of cytidine, which occurs up
to 500 times in a human cell each day [1]. Uracil in DNA
can also arise as a result of enzymatic deamination of cyti-
dine [2,3]. This is the obligatory initiating step in immu-
noglobulin (Ig) gene diversification, initiated by the B-cell
specific enzyme, Activation Induced Deaminase (AID) [4-
6]. In mammalian B cells, subsequent mutagenic process-
ing of AID-initiated lesions results in somatic hypermuta-
tion and class switch recombination. Somatic
hypermutation creates single base changes at the Ig varia-
ble (V) regions, providing a dynamic response to con-
stantly mutating pathogens, and – when coupled with
clonal selection – increased affinity of antibody for anti-
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gen. Class switch recombination deletes a large region of
chromosomal DNA, rejoining DNA ends within G-rich
switch (S) regions, and changing the constant region of
the expressed Ig molecule without altering antigen specif-
icity (reviewed by [2,7-9]).
Redundant pathways promote somatic hypermutation
and class switch recombination in mammalian B cells
[10,11]. One pathway depends upon uracil excision, car-
ried out by uracil nucleoside glycosylase (UNG); and the
other upon MutSα, a heterodimer of MSH2/MSH6. These
factors also function in high fidelity repair pathways. In
base excision repair, UNG excises uracil leaving an abasic
(AP) site to be cleaved by AP endonuclease 1 (APE1),
which is then repaired by pol β and DNA ligase 3 [1]. In
the mismatch repair pathway, MutSα recognizes mis-
matches or damaged bases, hydrolyses ATP, recruits
MutLα, promotes excision by Exonuclease I and then
resynthesis by the high fidelity DNA polymerase δ (pol δ)
in a reaction dependent upon proliferating cell nuclear
antigen (PCNA) and replication protein A (RPA)
(Reviewed by [12,13]).
The functional redundancy of the uracil excision and mis-
match recognition pathways in Ig gene diversification
raised the possibility that these pathways might also func-
tion redundantly in high fidelity repair of uracil in DNA.
Sequence analysis of non-Ig genes in murine germinal
center B cells has shown that AID acts widely, creating
U￿G mispairs which appear to be differentially subject to
low-fidelity or high-fidelity correction [14]. Consistent
with a potential role in repair of U￿G mismatches, MutSα
has been shown to specifically recognize heteroduplexes
containing U￿G in vitro, and to associate with targets of
AID activity in vivo [15,16]. However, repair of U￿G by the
MutSα-provoked mismatch repair pathway to promote
faithful correction of U￿G mismatches has not been dem-
onstrated.
We have now asked whether MutSα promotes repair at
U￿G mismatches in vitro. We show that purified human
MutSα can recognize U￿G but not U￿A pairs; while, in
contrast, UNG recognizes and removes uracil opposite
either G or A. Heteroduplexes containing U￿G pairs are
efficiently corrected by MutSα; and like canonical mis-
match repair of other base mismatches, efficient MutSα-
dependent repair of U￿G mismatches depends upon ATP,
PCNA, and pol δ. Thus, redundant pathways carry out
repair at UG, one pathway dependent upon UNG and the
other upon MutSα. Faithful MutSα-dependent repair of
heteroduplexes containing U￿G mismatches occurs at
comparable efficiency in extracts of B cells and non-B
cells, suggesting that events or factors specific to the Ig loci
of antigen-activated B cells must divert repair from a faith-
ful to a mutagenic pathway. The efficiency of MutSα-
directed repair of U￿G is comparable to that of the UNG-
directed pathway, and this may explain why, in humans,
UNG-deficiency imparts compromised immunity but nei-
ther a decrease in genomic stability nor a broad predispo-
sition to cancer.
Results
MutSα but not UNG Distinguishes U•G Mispairs from U•A 
Pairs in Duplex DNA
We compared the binding of human MutSα (hMutSα) to
synthetic DNA substrates containing U opposite either G
(U￿G) or A (U￿A), using a gel mobility shift assay.
hMutSα bound well to substrates containing U￿G mis-
matches (apparent kD of 70 nM; Figure 1A), but poorly to
substrates containing U￿A pairs, (apparent kD > 135 nM).
Competition analysis showed that binding of hMutSα to
a labeled duplex substrate containing a single U￿G mis-
match was unaffected by the presence of a 50-fold molar
excess of unlabeled duplex containing a U￿A pair, but
diminished more than 5-fold by a comparable amount of
duplex DNA containing a U￿G mismatch (Figure 1B).
These properties are consistent with previous binding
studies showing that hMutSα preferentially recognizes
U￿G or UU/GG heteroduplex oligonucleotides relative to
homoduplexes [15-17]; and evidence that duplexes con-
taining U￿G but not U￿A pairs activate MutSα ATPase
activity [18].
Substrate preference of purified recombinant human
UNG (hUNG) was analyzed by comparing deglycosyla-
tion activity on duplex substrates containing a U￿G mis-
pair or U￿A pair. Deglycosylation creates an abasic (AP)
site, which is alkali-labile, allowing ready quantitation of
UNG activity on end-labeled substrates by treatment with
alkali. hUNG had comparable activity on substrates con-
taining U￿A or U￿G (Figure 1C). This is consistent with
the documented ability of UNG to recognize unpaired
uracil [19]; and with the ability of repair complexes asso-
ciated with UNG to initiate short-patch base excision
repair on DNA containing U opposite either G or A [20].
Thus, in the repair of genomic uracil, base excision repair
responds to U￿A or U￿G while mismatch repair may spe-
cifically target U￿G heteroduplexes.
UNG-directed Repair of U•G Mispairs in Circular Duplex 
Substrates in Vitro
Specific recognition by hMutSα of DNA duplexes contain-
ing U￿G mispairs (Figure 1) suggested that, in human
cells, genomic uracil is corrected by MutSα-directed mis-
match repair pathway. To test this possibility, we devel-
oped circular ds DNA substrates containing a single U at a
defined position, which could be used to assay repair by
either pathway. These substrates were modeled on those
used to define the mechanism of MutSα-driven repair at
single-base mismatches and chemically modified bases,BMC Molecular Biology 2008, 9:94 http://www.biomedcentral.com/1471-2199/9/94
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MutSα but not UNG distinguishes U•G and U•A in duplex DNAs Figure 1
MutSα but not UNG distinguishes U•G and U•A in duplex DNAs. (A) Electrophoretic mobility shift assay of purified 
hMutSα (16, 32, 65 or 130 nM) binding to labeled DNA duplexes containing U•G mispairs (left) or U•A pairs (right). Arrows 
indicate bound and free DNA. The percentage of DNA bound is shown below. (B) Quantitation of binding of purified MutSα to 
radiolabeled U•G duplexes in the presence of indicated levels of unlabeled U•G or U•A duplex competitor. (C) Products of 
deglycosylation of DNA duplex substrates containing U•G mispairs or U•A pairs by 0, 0.2, 0.4, 0.8, or 1.6 nM of purified 
hUNG, resolved by denaturing gel electrophoresis. Substrates were 5' end labeled on the uracil-containing strand, and follow-
ing incubation with hUNG were treated with alkali to hydrolyze the backbone at abasic sites. The fraction of cleaved mole-
cules, quantified by phosphorimager, is shown below each lane.
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which contain a mismatched or damaged base at a
defined position and a single-strand DNA discontinuity
(nick or short gap) to direct repair to the strand containing
the damage [21-27]. A synthetic oligonucleotide carrying
a U within the single HindIII restriction site in the lacZα
gene was annealed to single-stranded circular M13mp18
DNA (Figure 2A, left); and then extended with the high-
fidelity Phusion polymerase (New England Biolabs),
which lacks both 5'-3' exonuclease and strand displace-
ment activity. This created a duplex circular molecule,
containing a single U￿G mismatch that interrupts the Hin-
dIII restriction site, and a strand discontinuity (nick or
short gap) 38 nt from the mismatch (Figure 2A, center).
This substrate, referred to henceforth as M13-U￿G, cannot
be cleaved by HindIII, which requires the correct palindro-
mic sequence (AAGCTT) on both DNA strands. The strand
UNG-directed repair of U•G mispairs in circular duplex substrates Figure 2
UNG-directed repair of U•G mispairs in circular duplex substrates. (A) Schematic for construction and repair of 
M13-U•G substrates. A 56-mer complementary oligonucleotide carrying a single U was annealed to ss M13mp18 to create a 
U•G mismatch within the HindIII restriction site (left); extended with Phusion polymerase to produce a nicked-circular duplex 
M13-U•G substrates (center); and repaired to create a functional HindIII site (right). (B) Reactions demonstrating repair of 
M13-U•G substrates by purified components of the base excision repair pathway, analyzed by agarose gel electrophoresis. 
Shown are unrepaired, undigested M13-U•G substrates; and substrates treated with UNG, APE1 and pol β and then digested 
with HindIII and Bme 1580 I, as indicated. Arrows at left indicate undigested nicked circles, and unrepaired and repaired prod-
ucts; schematic at right diagrams products of HindIII and Bme 1580 I digestion.
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discontinuity will direct mismatch repair to the strand
containing the single U, and repair of U￿G to C￿G will cre-
ate a site cleavable by HindIII (Figure 2A, right). Substrates
contain a single Bme 1580 I site remote from the mis-
match. Simultaneous digestion of the unrepaired sub-
strate with Bme 1580 I and HindIII will create a single
linear fragment 7.3 kb in length; while digestion of
repaired DNA will generate two fragments, of 4.2 and 3.1
kb. The ratio of these two fragments to total DNA provides
a measure of efficiency of repair.
We confirmed that the M13-U￿G ds substrates could
report on repair by the UNG-dependent base excision
pathway by assaying reconstitution of the HindIII site
after sequential incubation with purified hUNG, hAPE1,
and DNA polymerase β (pol β), members of the UNG-
directed base excision repair pathway. HindIII was unable
to cleave M13-U￿G following incubation with UNG, or
UNG and APE1; however, subsequent incubation with
pol β resulted in 68% cleavage by HindIII (Figure 2B).
Therefore, the M13-U￿G circular substrates sensitively
monitor reconstitution of the HindIII site by in vitro
repair.
UNG-independent Repair of U•G Mispairs in Human 
Nuclear Extracts
To distinguish the contributions of MutSα and UNG to
repair of U￿G mismatches, we first asked how inhibition
of UNG affected repair of M13-U￿G circular substrates in
human cell extracts. The small protein, uracil glycosylase
inhibitor (Ugi), encoded by bacteriophage PBS2, is spe-
cific for UNG homologs and forms a 1:1 complex with the
DNA binding domain of UNG, blocking uracil excision in
vitro  and in vivo [28-31]. We prepared nuclear extracts
from three human cell lines: HeLa, derived from an aden-
ocarcinoma [22,32]; Ramos, derived from an actively
hypermutating B cell lymphoma [33]; and LoVo, derived
from an MSH2-deficient colorectal carcinoma [34]. All
three extracts showed high levels of uracil DNA glycosy-
lase activity; and Ugi completely inhibited deglycosyla-
tion in all three extracts (Figure 3A). There are other uracil
DNA glycosylases in human cells, including MBD4, TDG,
and SMUG1, which are divergent from UNG [35] and
therefore should be insensitive to Ugi. The fact that uracil
DNA glycosylase activity could not be observed in the
presence of Ugi confirms that UNG is the predominant
activity for deglycosylation of uracil in these extracts; and
shows that treatment of human nuclear extracts with Ugi
can be used to distinguish UNG-directed base excision
repair from UNG-independent repair.
We then assayed repair of M13-U￿G circular substrates in
nuclear extracts prepared from HeLa and the constitu-
tively hypermutating B cell line, Ramos, in the presence or
absence of Ugi. HeLa nuclear extracts supported repair of
52% of the molecules containing U￿G mismatches, and
this diminished to 35% in the presence of Ugi (Figure 3B).
Ramos supported repair of 64% of the molecules contain-
ing U￿G mismatches, and this diminished to 32% in the
presence of Ugi (Figure 3B). Repair values in the absence
of Ugi are consistent with published values for correction
of single base mismatches by human mismatch repair in
vitro [22-25,32]. U￿G mismatch repair in Ugi-treated
extracts was reproducible. Repair efficiency of U￿G in
three independent experiments averaged 33% repair (S.E.
1.76%) in Ugi-treated HeLa extracts; and 32% (S.E.
1.45%) in Ugi-treated Ramos extracts. Thus, Ugi-sensitive,
UNG-directed repair accounts for 30–50% of repair of
U￿G mispairs in Ramos or Hela extracts, while the
remainder (and major fraction) of repair is Ugi-insensitive
and UNG-independent. Because Ugi blocked detectable
uracil glycosylase activity in HeLa and Ramos nuclear
extracts (Figure 3A), Ugi-insensitive repair must be carried
out by activities independent of base excision repair.
MutSα and UNG Provide Redundant Pathways for Repair 
of U•G Mispairs
To ask if MutSα can direct repair of U￿G mispairs, we
assayed repair of the M13-U￿G circular substrates in Ugi-
treated extracts derived from the MSH2-deficient cell line
LoVo. Mismatch repair is defective in LoVo extracts but
can be restored in vitro by addition of purified hMutSα
[23,24,32,36,37]. Nuclear extracts of LoVo, treated with
Ugi to inhibit UNG (e.g. Figure 3A), supported repair of
only 8% of the M13-U￿G substrates (Figure 4A). Addition
of purified hMutSα to Ugi-treated LoVo nuclear extracts
increased repair 3-fold, to 24% (Figure 4A). Thus, MutSα
promotes efficient repair of U￿G mispairs.
We then asked if MutSα-dependent repair of U￿G mis-
pairs requires pol δ, ATP, and PCNA, all essential for
canonical mismatch repair in vitro [38-40]. Pol δ activity
and mismatch repair are both blocked by aphidicolin
[38,41]. In a control experiment, we established that
aphidicolin does not block the mutagenic polymerase pol
η, which is strongly implicated in MutSα-directed hyper-
mutation [42,43], by showing that aphidicolin did not
affect extension by pol η of a 5'-end-labeled 29-mer oligo-
nucleotide annealed to a 50-mer template to produce a
predicted 44-mer duplex extension product (Figure 4B).
However, aphidicolin almost completely prevented repair
of M13-U￿G mispair substrates in Ugi-treated HeLa and
Ramos nuclear extracts, diminishing repair to 5%, from
35% (HeLa) and 32% in Ramos (Figure 4C). This shows
that pol δ participates in MutSα-directed repair of U￿G
mispairs. The low level of repair evident in Ugi-treated
nuclear extracts in the presence of aphidicolin may be due
to participation of aphidicolin-resistant polymerases.BMC Molecular Biology 2008, 9:94 http://www.biomedcentral.com/1471-2199/9/94
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UNG directs repair of only a fraction of U•G mispairs in human nuclear extracts Figure 3
UNG directs repair of only a fraction of U•G mispairs in human nuclear extracts. (A) Products of deglycosylation of 
a 5'-end-labeled single-stranded oligonucleotide containing a single uracil, following incubation with recombinant UDG or 
nuclear extracts prepared from HeLa, Ramos, and LoVo cell lines in the presence (+) or absence (-) of Ugi. Substrates were 
treated with alkali following incubation to hydrolyze the backbone at abasic sites. Arrows indicate substrate and product. (B) 
Representative reactions demonstrating repair of M13-U•G substrates by nuclear extracts of HeLa or Ramos, in the presence 
(+) or absence (-) of Ugi, analyzed by agarose gel electrophoresis. Arrows at left indicate unrepaired and repaired products; 
fragment sizes are shown at right; fraction of molecules repaired is shown below each lane.
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MutSα directs faithful repair of U•G mispairs in human nuclear extracts Figure 4
MutSα directs faithful repair of U•G mispairs in human nuclear extracts. (A) Representative reactions demonstrating 
repair of M13-U•G substrates by Ugi-treated LoVo nuclear extracts, in the absence (-) or presence (+) of 53 nM purified 
hMutSα. Arrows at left indicate unrepaired and repaired products; fraction of molecules repaired is shown below each lane. 
(B) Products of extension by pol η in the absence or presence of aphidicolin. Arrows at left indicate primer and extension 
product. (C) Representative reactions demonstrating repair of M13-U•G substrates by Ugi-treated HeLa or Ramos nuclear 
extracts, in the presence and absence of aphidicolin, which inhibits pol δ; PBP, the PCNA binding peptide, which inhibits PCNA; 
or exogenous ATP. Notations as in panel A.
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PCNA binding protein (PBP) inhibits excision and DNA
resynthesis during mismatch repair by blocking PCNA
function [38,40]. Repair of M13-U￿G mispair substrates
was essentially abolished when PBP was added to Ugi-
treated nuclear extracts (Figure 4C). Thus, UNG-inde-
pendent repair of U￿G mispairs depends upon PCNA.
Omission of ATP caused the percentage of molecules
repaired to decrease from 35% to 10% in Ugi-treated
HeLa nuclear extracts; and from 32% to 9% in Ugi-treated
Ramos nuclear extracts (Figure 4C). Low levels of ATP in
the extracts may account for repair in the absence of exog-
enous ATP.
The dependence of repair of M13-U￿G substrates on
MutSα, PCNA, pol δ, and ATP, establishes that the canon-
ical mismatch repair pathway can correct U￿G mis-
matches in duplex DNA molecules.
High Fidelity Repair of U•G Mispairs in Extracts of a 
Hypermutating Human B Cell Line
Comparable levels of U￿G repair were observed in nuclear
extracts of HeLa and the hypermutating B cell line, Ramos
(Figures 3 and 4), suggesting that hypermutation does not
reflect compromised function of faithful repair pathways.
To further characterize repair fidelity, we used an assay
that measures inactivation of β-galactosidase due to muta-
genesis that occurs during synthesis across a gap in the
lacZα gene in M13mp18 phage, quantitating the fraction
of clear or pale blue plaques produced upon transforma-
tion of E. coli followed by plating on a helper lawn on X-
gal plates [44]. This assay provides convenient compari-
son of mutation frequencies under different conditions,
but underestimates total mutation frequency because not
all mutations affect β-galactosidase activity. As a positive
control, we used the M13-Gap51 substrate, in which a 51
nt gap, extending from the site of the mismatch at the Hin-
dIII site (position 6281) to the EcoRI site (position 6230)
near the 5' end of lacZα  (Figure 5A), recapitulates the
short excision tract created during mismatch repair of the
M13-U￿G substrate. We compared mutagenesis following
incubation of M13-Gap51 substrates with either the faith-
ful polymerase, Taq, or the mutagenic polymerase, pol η,
to fill the gap. The proportion of clear or pale blue plaques
was 2.5 × 10-3 following by gap filling by Taq, and 1.3 ×
10-2 following gap filling by pol η (Figure 5B). These num-
bers are significantly different (P  = 0.001, two-tailed
Fisher's exact test), confirming that this assay provides a
sensitive measure of mutagenesis.
We used the same assay to determine the frequency of β-
galactosidase inactivation in the M13-U￿G substrates. The
background frequency of β-galactosidase inactivation evi-
dent upon direct transformation of E. coli with unrepaired
M13-U￿G substrates was 1.3 × 10-3 (Figure 5B). When
M13-U￿G substrates were incubated in Ugi-treated Ramos
extracts to allow repair to occur prior to transformation,
the proportion of clear or pale blue plaques was 1.8 × 10-
3, not significantly different from unrepaired M13-U￿G
substrates (P = 0.77, two-tailed Fisher's exact test; Figure
5B). Parallel analysis showed that the fraction of repaired
substrates, as assayed by HindIII-sensitivity, was 34%,
comparable to the efficiency of repair in Ugi-treated
Ramos nuclear extracts (not shown). Thus, the extracts
were active for repair, but mutagenesis appeared not to
accompany repair.
The plaque color-based mutagenesis assay scores only
mutations that inactivate β-galactosidase. To ensure that
this assay did not greatly underestimate the mutation fre-
quency, we sequenced randomly selected blue plaques
arising from M13-U￿G incubated in the repair extract
prior to transformation of E. coli. A majority of the exci-
sion tracts initiated by in vitro mismatch repair of nick-cir-
cular substrates terminate between 90 and 170 bases from
the mismatch [45]. We therefore analyzed a 200 nt region
bordered by the strand discontinuity and encompassing
DNA upstream of the mismatch site (Figure 2A) for muta-
tions induced in the course of nick-directed uracil repair.
Within this region, we did not find significant mutagene-
sis of UG-M13 substrates incubated with Ugi-treated HeLa
extract (57 plaques, no mutations, 11,400 nt sequenced)
or from Ramos nuclear extract (93 plaques, 1 mutation,
18,600 nt sequenced). Thus, in contrast to pol η-directed
gap filling, repair of U￿G by the human nuclear extracts
was not mutagenic.
Discussion
We have shown that multiple repair pathways may correct
genomic uracil. This is consistent with published evidence
showing that deficiency in UNG activity in humans is
most evident as immunodeficiency, rather than as predis-
position to malignancies [46,47]. Similarly, disruption of
the murine Ung gene did not result in greatly increased
levels of spontaneous mutations [48], although it did
cause immunodeficiency [11]. This has been ascribed to
the presence of redundant factors which can deglycosylate
uracil, such as SMUG1, TDG, or MBD4 [35]. Our results
now suggest that MutSα may provide an equally impor-
tant pathway for faithful repair of uracil in DNA.
These results expand the scope of substrates known to be
repaired by hMutSα to include U￿G heteroduplexes.
hMutSα interacts nonspecifically with homoduplex DNA
[49], but specifically recognizes a broad array of sub-
strates, including single-base mismatches and small loops
[21,36]; base alterations such as 8-oxoguanine paired
opposite thymine [23,49]; O6-alkylguanine and cisplati-
nated guanine [50], UV photoproducts [17]; and alsoBMC Molecular Biology 2008, 9:94 http://www.biomedcentral.com/1471-2199/9/94
Page 9 of 13
(page number not for citation purposes)
alternatively structured DNA, such as Holliday junctions
and G4 DNA [15,51].
The UNG-directed and MutSα-directed U￿G repair path-
ways were comparably efficient in the actively hypermu-
tating B cell line, Ramos, and in HeLa cells. The evidence
that U￿G repair is not intrinsically mutagenic in B cells
suggests that a localized mechanism may divert repair at
diversifying Ig genes, enabling mutagenic pathways to co-
opt normally faithful repair pathways. Hypermutating Ig
V regions exhibit enrichment of the MRN complex and
associated MRE11 AP lyase activity, but not of APE1; and
cleavage by MRE11 rather than APE1 may divert repair to
low-fidelity pathways [52]. MutSα interacts with pol η
[16], which could promote low fidelity repair in the
course of resynthesis through the excision tract [2,42].
Ubiquitination of PCNA provides one possible mecha-
nism for regulating the switch between pol δ and pol η
[53].
The Ig gene diversification apparatus takes advantage of
differences between the UNG-directed and MutSα-
directed repair pathways to ensure that mutations spread
beyond the C/G pairs, the site of AID activity. In faithful
repair MutSα recruits Exonuclease I, which promotes exci-
sion from a nick through the region containing the mis-
match. In Ig gene hypermutation, MutSα promotes
mutagenesis at A/T pairs, which are not AID targets, in a
process dependent upon both the MSH2 ATPase [54] and
Exonuclease I [55]. In contrast, at hypermutating Ig genes
UNG promotes mutagenesis at C/G pairs, the sites of AID-
initiated DNA damage [56], recapitulating the very lim-
ited excision and resynthesis of a single nucleotide typical
of faithful repair directed by UNG, APE1 and DNA
polymerase β [1].
Nuclear extracts from the hypermutating B cell line, Ramos, support faithful repair of U•G mispairs Figure 5
Nuclear extracts from the hypermutating B cell line, Ramos, support faithful repair of U•G mispairs. (A) Sche-
matic of M13-Gap51 substrates, which carry a 51 nt gap in the lacZα region of M13mp18. (B) Efficiency of repair of M13-Gap51 
or M13-U•G substrates, determined by quantitating the fraction of clear and pale blue plaques on X-gal indicator plates. P val-
ues were determined by two-tailed Fisher's exact test.
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It is not yet known whether strand-specificity governs
MutSα-dependent events at the Ig genes of diversifying B
cells, or the time in the cell cycle that diversification
occurs. Nonetheless, it is important to note that if MutSα
directs post-replicative repair, and if the uracil in a U￿G
mispair is located on the parental strand, function of
MutSα would result in a G→A transition mutation, not
correcting but "fixing" the mutation. A similar paradoxical
situation has been noted for MutSα-directed repair of
parental-strand base damage, such as 8-oxouanine [23],
O6-alkylguanine [27,57] and UV photoproducts [17].
Diversifying Ig genes could capitalize on this apparently
paradoxical function to increase the level of mutagenesis,
by regulating AID attack and participation of MutSα
within cell cycle. Future experiments should address this
possibility.
Conclusion
We have directly demonstrated by biochemical assays that
human MutSα can direct faithful correction of U￿G mis-
matched DNA via the canonical mismatch repair path-
way. These results identify redundant roles for mismatch
repair and base excision repair in correction of genomic
uracil in the cell. Moreover, they show that participation
of these pathways in immunoglobulin gene diversifica-
tion reflect their redundant functions in faithful repair.
Methods
Proteins and Nuclear Extracts
Human UNG2 (hUNG) was PCR amplified from cDNA
from the Ramos cell line using primers 5'-
CACCATGATCGGCCAGAAGACGCTCTACTCCTTTT-
TCTC and 5'- TCACAGCTCCTTCCAGTCAATGGGCT-
TCTTGCC; and cloned downstream of the T7 promoter in
pET100 (Invitrogen, Carlsbad, CA), providing an N-termi-
nal His6 tag. Following sequence confirmation, the hUNG
plasmid was used to transform E. coli BL21 DE3 pLysS
(Invitrogen), in which T7 RNA polymerase is expressed
under control of the lactose repressor. Mid-log cells were
cultured at 37°C for 2 hr with 1 mM IPTG to induce T7
polymerase expression; collected by centrifugation; fro-
zen; resuspended in 50 ml of lysis buffer containing 20
mM Tris pH 7.7, 300 mM NaCl, 0.5 mM DTT, and a pro-
tease inhibitor mini-tablet (Roche, Indianapolis, IN); son-
icated twice for 20 seconds, and cell debris removed by
centrifugation. hUNG was purified by Ni++ chromatogra-
phy (Sigma, St. Louis, MO) according to manufacturer's
instructions, followed by S-Sepharose gravity flow chro-
matography (GE, Piscataway, NJ). hAPE1 was purified as
described previously [52]. Pol β was purchased from
Trevigen (Gaithersburg, MD). MutSα was overexpressed
by co-infecting Sf9 insect cells with baculovirus vectors
expressing MSH2 and MSH6 and purified as previously
described [15]. HeLa, Ramos, and LoVo cells were sup-
plied by the National Cell Culture Center (Minneapolis,
MN) as pellets stored on wet ice, and nuclear extracts were
prepared as previously described [37]. Protein concentra-
tions were determined using BSA as a standard.
DNA Substrates
Synthetic duplexes carrying U￿G mismatches were created
by annealing EDL56, 5'-GCCGAATTTCTAGAATU-
GAAAGCTTGCTAG-3', to EDL364, 5'-CTAGCAAGCTTTC-
GATTCTAGAAATTCGGC-3'; U￿A duplexes were
generated by annealing EDL56 to EDL365, 5'-CTAG-
CAAGCTTTCAATTCTAGAAATTCGGC-3'; and homodu-
plexes were generated by annealing EDL365 to EDL366,
5'- GCCGAATTTCTAGAATTGAAAGCTTGCTAG-3'. Oligo-
nucleotides were 5'-end labeled using T4 PNK (NEB, Ips-
wich, MA) and γ-32P-ATP. To generate labeled duplexes,
EDL56 was 5'-end-labeled prior to annealing. A single-
stranded 50-mer oligonucleotide, 5'-CAGAAAGGGAAAG
TATACAACAAAAAGCAUCTCAAGTCTTGGAGAGAACA,
was used to assay hUNG activity in nuclear extracts. Exten-
sion assays using pol η were primed from 5' end labeled
EDL145, 5'-CAGAAAGGGAAAGTATACAACAAAAAGCA-
3' annealed to EDL119, 5'- CTCCAAGACTTGAGGTGCTT
TTTGTTGTATACTTTCCCTTTCTGTGACCT-3'.
M13-U￿G double-stranded (ds) circular substrates for
mismatch repair assays were designed to carry a single
U￿G mismatch within a HindIII restriction site, and a 5'
strand discontinuity (nick or short gap) on the strand tar-
geted for repair [22,25,58]. M13mp18 circular single-
stranded (ss) (+) strand DNA (NEB) was annealed to
PAGE purified oligonucleotide EDL330, 5'-
CCCAGTCACGACGTTGTAAAACGACGGCCAGT-
GCCAAGUTTGCATGCCTGCAGGTC, in a 1.4 ml reaction
that contained 13.7 μg M13mp18 DNA, 80 pmol
EDL330, 0.2 mM dNTPs, in Phusion polymerase HF
buffer (NEB), to create a U￿G mismatch at position 6283
(underlined); extended with Phusion polymerase (14 U)
at 65°C for 45 min; and duplex extension products sepa-
rated from other reaction components by two rounds of
purification on PCR-pure spin columns (Qiagen, Valen-
cia, CA). To ensure that no homoduplex molecules were
present (which could in principle be produced by strand
displacement, although this is not a reported activity of
Phusion polymerase), products were digested with Hin-
dIII (1 U/μg substrate); single-stranded M13mp18 was
removed by BND cellulose chromatography (Sigma, St
Louis, MO); and linear molecules destroyed by treatment
with Exonuclease V (USB, Cleveland, OH). Following eth-
anol precipitation, M13-U￿G ds circles were shown to co-
migrate with nicked, duplex M13mp18 upon 1% agarose
gel electrophoresis (420 V￿hr).
Repair Activity and Binding Assays
Uracil repair and binding assays results were confirmed by
repetition and representative results are presented. ImagesBMC Molecular Biology 2008, 9:94 http://www.biomedcentral.com/1471-2199/9/94
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were captured and analyzed by phosphorimager (GE) or
captured and quantified by an AlphaInnotech HD2 sys-
tem and presented as reversed ethidium bromide stained
images as indicated for each assay.
MutSα binding assays were performed in 30 μl reactions
containing 25 mM Tris pH 7.7, 100 mM KCl, 1 mM EDTA,
1 mM DTT, 7.5% glycerol, with indicated concentrations
of purified MutSα, 10 fmol radiolabeled heteroduplex,
and indicated concentrations of homoduplex oligonucle-
otide competitor DNA (annealed EDL365/EDL366). Fol-
lowing incubation on ice for 5 min, reactions were
brought to 0.7% Ficoll, and then resolved by 6% native
PAGE in 0.5 × TBE. For competition experiments, indi-
cated concentrations of unlabeled U￿G (EDL56/EDL364)
or U￿A (EDL56/EDL365) duplexes were added prior to
addition of protein.
UNG activity was assayed by quantitating production of
the alkaline-labile abasic site generated upon deglycosyla-
tion of uracil. Purified recombinant hUNG (40 to 2.5
fmols) and 50 fmols of U￿G (EDL56/EDL364) or U￿A
(EDL56/EDL365) synthetic duplexes were incubated in
25 μl reactions containing 10 mM Tris, 1 mM EDTA, 37°C
for 15 min; treated with 0.25% SDS, 10 mM EDTA and
100 μg/ml Proteinase K (Promega, Madison, WI) at 37°C
for 10 min; and then with 0.1 N NaOH at 37°C for 5 min.
Following addition of an equal volume of formamide,
cleavage products were resolved by 15% denaturing
PAGE. Images were captured and quantified by phos-
phorimager. UNG activity present in human nuclear
extracts was determined by a similar procedure, using 50
μg of nuclear extract and 50 fmols of 5'-end-labeled
EDL58 oligonucleotide in 30 μl reactions containing 20
mM Tris pH 7.7, 100 mM KCl, 5 mM MgCl2, 1 mM glu-
tathione, 1.5 mM ATP, 0.1 mM each dNTP, and 50 μg/ml
BSA for 20 min at 37°C. Ugi (NEB, 2 U in 1 μl) was added
to inhibit UNG.
Mismatch repair assays followed a published protocol
[22]. M13-U￿G ds circular substrates (13.6 fmol) were
incubated with 50 μg of nuclear extract in 30 μl reactions
containing 20 mM Tris pH 7.7, 100 mM KCl, 5 mM
MgCl2, 1 mM glutathione, 1.5 mM ATP, 0.1 mM each
dNTP, and 50 μg/ml BSA for 20 min at 37°C. In some
cases, recombinant human MutSα (hMutSα) was added
(1.6 pmol), or pol δ was inhibited with aphidicolin (183
μM; Sigma); or PCNA was inhibited by addition of PCNA
binding protein (PBP, American Peptide Company Sun-
nyvale, CA), as described [24]. Reactions were terminated
by addition of 15 μl (one-half volume) 1% SDS, 25 mM
EDTA pH 8, 0.1 mg/ml Proteinase K; and following phe-
nol extraction and ethanol precipitation, DNA was resus-
pended in 1× NEB Buffer 2 supplemented with 100 μg/ml
RNAse A, 100 μg/ml BSA. DNA was then cleaved by simul-
taneous digestion with Bme 1580 I (1 U), which linearizes
M13mp18 at position 2088; and HindIII (1 U), which
cleaves only those molecules in which the U￿G mismatch
has been converted to a C￿G pair in the course of DNA
resynthesis, creating a HindIII site (AAGCTT) at position
6281. Digestion products were resolved by 1% agarose gel
electrophoresis, gels stained with ethidium bromide, and
images captured and quantified using an AlphaInnotech
HD2 imaging system. Representative images are presented
as reversed ethidium bromide stained images.
Pol η Extension Assay
The activity pol η was measured by extension of 5'-32P-
labeled oligonucleotide EDL145, annealed to EDL119,
with 160 fmols purified recombinant pol η (Enzymax,
Lexington, KY), in buffer conditions identical to those
used for mismatch repair assays (20 mM Tris pH 7.7, 100
mM KCl, 5 mM MgCl2 1 mM glutathione, 1.5 mM ATP,
0.1 mM each dNTP, and 50 μg/ml BSA), in the presence
or absence of 180 μM aphidicolin. The 44-mer extension
product was distinguished from the EDL145 29-mer
primer by 15% denaturing PAGE.
Repair Fidelity Assay
The assay for fidelity of U￿G heteroduplex repair was
based on an assay developed for quantitating DNA
polymerase fidelity on gapped M13mp2 molecules [44].
Control M13-Gap51 substrates, containing a 51 nt gap
within the lacZα gene of M13mp18, were generated by
annealing a 10-fold molar excess of M13mp18 ssDNA cir-
cles to a slightly shorter complementary strand, produced
by digestion of duplex M13 with EcoR1 and HindIII, and
removal of the 51 bp fragment using a PCR purification
column (Qiagen). Unpaired linear single strands and any
circular single-stranded M13mp18 were removed by BND
cellulose chromatography and duplex linear DNA was
removed by digestion with Exonuclease V (USB). The gap
in M13-Gap51 was filled with either Taq polymerase (1 U,
NEB) or 160 fmols pol η (12.5 ng), under manufacturer's
standard conditions. Repair was carried out in 30 μl reac-
tions in the same conditions as the mismatch repair assay
(above). Recovered DNA was resuspended in 30 μl TE,
and repair at the HindIII site was quantitated by digestion
of a 5 μl aliquot with Bme 1580 I and HindIII followed by
gel electrophoresis, as described above. Repair fidelity was
analyzed by a plaque assay for β-galactosidase activity, in
which E. coli MC1061 was transformed with 1.4 ng of
DNA by electroporation, transformants plated with the
helper strain CSH50, on minimal glucose media contain-
ing X-gal (Sigma) and unmutated (blue), or mutated (pale
blue or clear) plaques quantitated. E. coli strains were pro-
vided by Dr. Lawrence A. Loeb, University of Washington,
Seattle, WA.BMC Molecular Biology 2008, 9:94 http://www.biomedcentral.com/1471-2199/9/94
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